{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T08:03:54Z","timestamp":1773302634364,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2005,3,15]],"date-time":"2005-03-15T00:00:00Z","timestamp":1110844800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1007\/s00520-005-0790-y","type":"journal-article","created":{"date-parts":[[2005,3,14]],"date-time":"2005-03-14T08:06:04Z","timestamp":1110787564000},"page":"790-796","source":"Crossref","is-referenced-by-count":36,"title":["A randomised, double-blinded, placebo-controlled, pilot study of parenteral glutamine for allogeneic stem cell transplant patients"],"prefix":"10.1007","volume":"13","author":[{"given":"N. M. A.","family":"Blijlevens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. P.","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. H. J.","family":"Naber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. V. M. B.","family":"Schattenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. E.","family":"dePauw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,3,15]]},"reference":[{"issue":"8","key":"790_CR1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1753-4887.1990.tb02967.x","volume":"48","author":"JM Lacey","year":"1990","unstructured":"Lacey JM, Wilmore DW (1990) Is glutamine a conditionally essential amino acid? Nutr Rev 48(8):297\u2013309","journal-title":"Nutr Rev"},{"issue":"5","key":"790_CR2","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0002-9610(96)00217-6","volume":"172","author":"VS Klimberg","year":"1996","unstructured":"Klimberg VS, McClellan JL, Organ CH Jr (1996) Honorary lectureship. Glutamine, cancer, and its therapy. Am J Surg 172(5):418\u2013424","journal-title":"Am J Surg"},{"key":"790_CR3","doi-asserted-by":"crossref","first-page":"2578S","DOI":"10.1093\/jn\/131.9.2578S","volume":"131","author":"TR Ziegler","year":"2001","unstructured":"Ziegler TR (2001) Glutamine supplementation in cancer patients receiving bone marrow transplantation and high dose chemotherapy. J Nutr 131:2578S\u20132584S","journal-title":"J Nutr"},{"issue":"4","key":"790_CR4","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/sj.bmt.1701317","volume":"22","author":"PM Anderson","year":"1998","unstructured":"Anderson PM, Ramsay NKC, Shu XO, Rydholm N, Rogosheske J, Nicklow R et al (1998) Effect of low-dose oral glutamine on painful stomatitis during bone marrow transplantation. Bone Marrow Transplant 22(4):339\u2013344","journal-title":"Bone Marrow Transplant"},{"key":"790_CR5","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/sj.bmt.1702447","volume":"25","author":"NMA Blijlevens","year":"2000","unstructured":"Blijlevens NMA, Donnelly JP, De Pauw BE (2000) Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview. Bone Marrow Transplant 25:1269\u20131278","journal-title":"Bone Marrow Transplant"},{"key":"790_CR6","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/cncr.11671","volume":"98","author":"LS Elting","year":"2003","unstructured":"Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E, Rubenstein EB (2003) The burdens of cancer therapy: clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 98:1531\u20131539","journal-title":"Cancer"},{"key":"790_CR7","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1200\/JCO.1999.17.8.2446","volume":"17","author":"AP Rapoport","year":"1999","unstructured":"Rapoport AP, Miller Watelet LF, Linder T, Rberly S, Raubertas RF, Lipp J et al (1999) Analysis of factors that correlate with mucositis in recipients of autologous and allogeneic stem-cell transplants. J Clin Oncol 17:2446\u20132453","journal-title":"J Clin Oncol"},{"issue":"8","key":"790_CR8","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1200\/JCO.2001.19.8.2201","volume":"19","author":"ST Sonis","year":"2001","unstructured":"Sonis ST, Oster G, Fuchs H, Bellm L, Bradford WZ, Edelsberg J et al (2001) Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol 19(8):2201\u20132205","journal-title":"J Clin Oncol"},{"issue":"6","key":"790_CR9","first-page":"409","volume":"9","author":"JP Donnelly","year":"1992","unstructured":"Donnelly JP, Muus P, Schattenberg A, De Witte T, Horrevorts A, DePauw BE (1992) A scheme for daily monitoring of oral mucositis in allogeneic BMT recipients. Bone Marrow Transplant 9(6):409\u2013413","journal-title":"Bone Marrow Transplant"},{"key":"790_CR10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00520-003-0572-3","volume":"12","author":"NMA Blijlevens","year":"2004","unstructured":"Blijlevens NMA, van\u2019t Land B, Donnelly JP, M\u2019Rabet L, DePauw BE (2004) Measuring mucosal damage induced by cytotoxic therapy. Support Care Cancer 12:227\u2013233","journal-title":"Support Care Cancer"},{"issue":"3","key":"790_CR11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/sj.bmt.1704563","volume":"34","author":"NMA Blijlevens","year":"2004","unstructured":"Blijlevens NMA, Lutgens LCHW, Schattenberg AVMB, De Pauw BE (2004) Citrulline: a potentially simple quantitative marker of intestinal epithelial damage following myeloablative therapy. Bone Marrow Transplant 34(3):193\u2013196","journal-title":"Bone Marrow Transplant"},{"key":"790_CR12","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1046\/j.1365-2141.1997.d01-3499.x","volume":"98","author":"N Schaap","year":"1997","unstructured":"Schaap N, Schattenberg A, Bar B, Preijers F, Geurts van Kessel A, van der Maazen R et al (1997) Outcome of transplantation for standard-risk leukaemia with grafts depleted of lymphocytes after conditioning with an intensified regimen. Br J Haematol 98:750\u2013759","journal-title":"Br J Haematol"},{"issue":"1","key":"790_CR13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","volume":"16","author":"DW Cockcroft","year":"1976","unstructured":"Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16(1):31\u201341","journal-title":"Nephron"},{"issue":"6","key":"790_CR14","first-page":"409","volume":"9","author":"JP Donnelly","year":"1992","unstructured":"Donnelly JP, Muus P, Schattenberg A, De Witte T, Horrevorts A, DePauw BE (1992) A scheme for daily monitoring of oral mucositis in allogeneic BMT recipients. Bone Marrow Transplant 9(6):409\u2013413","journal-title":"Bone Marrow Transplant"},{"key":"790_CR15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0009-8981(86)90303-7","volume":"157","author":"G Jansen","year":"1986","unstructured":"Jansen G, Muskiet FAJ, Schierbeek H, Berger R, Van melle G (1986) Capillary gas chromatographic profiling of urinary, plasma and erythrocyte sugars and polyols as their trimethylsilyl derivates, preceded by a simple and rapid prepurification method. Clin Chim Acta 157:277\u2013294","journal-title":"Clin Chim Acta"},{"key":"790_CR16","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1097\/00003246-199607000-00013","volume":"24","author":"JD Johnston","year":"1996","unstructured":"Johnston JD, Harvey CJ, Menzies IS, Treacher DF (1996) Gastrointestinal permeability and absorptive capacity in sepsis. Crit Care Med 24:1144\u20131149","journal-title":"Crit Care Med"},{"key":"790_CR17","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3109\/00365529309096090","volume":"28","author":"SG Lim","year":"1993","unstructured":"Lim SG, Menzies IS, Lee CA, Johnson MA, Pounder RE (1993) Intestinal permeability and function in patients infected with Human Immunodeficiency Virus: a comparison with Coeliac Disease. Scand J Gastroenterol 28:573\u2013580","journal-title":"Scand J Gastroenterol"},{"key":"790_CR18","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/sj.bmt.1703759","volume":"30","author":"R Pytlik","year":"2004","unstructured":"Pytlik R, Benes P, Patorkova M, Chocenska E, Gregora E, Prochazka B et al (2004) Standardized parenteral alanyl-glutamine dipeptide supplementation is not beneficial in autologous transplant patients: a randomized, double-blind, placebo controlled study. Bone Marrow Transplant 30:953\u2013961","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"790_CR19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/cncr.20733","volume":"103","author":"LC Lutgens","year":"2005","unstructured":"Lutgens LC, Blijlevens NM, Deutz NE, Donnelly JP, Lambin P, de Pauw BE (2005) Monitoring myeloablative therapy-induced small bowel toxicity by serum citrulline concentration: a comparison with sugar permeability tests. Cancer 103(1):191\u2013199","journal-title":"Cancer"},{"issue":"11","key":"790_CR20","first-page":"1229","volume":"85","author":"G Canovas","year":"2000","unstructured":"Canovas G, Leon-Sanz M, Gomez P, Angeles Valero M, Gomis P, La Huerta JJ (2000) Oral glutamin supplements in autologous hematopoietic transplants: impact on gastro-intestinal toxicity and plasma protein levels. Haematologica 85(11):1229\u20131230","journal-title":"Haematologica"},{"issue":"2","key":"790_CR21","first-page":"192","volume":"88","author":"N Piccirillo","year":"2003","unstructured":"Piccirillo N, De Matteis S, Laurenti L, Chiusolo P, Sora F, Pittiruti M et al (2003) Glutamine-enriched parenteral nutrition after autologous peripheral blood stem cell transplantation: effects on immune reconstitution and mucositis. Haematologica 88(2):192\u2013200","journal-title":"Haematologica"},{"issue":"10","key":"790_CR22","doi-asserted-by":"crossref","first-page":"821","DOI":"10.7326\/0003-4819-116-10-821","volume":"116","author":"TR Ziegler","year":"1992","unstructured":"Ziegler TR, Young LS, Benfell K, Scheltinga M, Hortos K, Bye R et al (1992) Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study. Ann Intern Med 116(10):821\u2013828","journal-title":"Ann Intern Med"},{"issue":"5","key":"790_CR23","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1177\/0148607193017005407","volume":"17","author":"PR Schloerb","year":"1993","unstructured":"Schloerb PR, Amare M (1993) Total parenteral nutrition with glutamine in bone marrow transplantation and other clinical applications (a randomized, double-blind study) [see comments]. J Parenter Enter Nutr 17(5):407\u2013413","journal-title":"J Parenter Enter Nutr"},{"key":"790_CR24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/ajcn\/72.1.181","volume":"72","author":"CR Jonas","year":"2000","unstructured":"Jonas CR, Puckett AB, Jones DP, Griffith DP, Szesycki EE, Bergman GF et al (2000) Plasma antioxidant status after high-dose chemotherapy: a randomized trial of parenteral nutrition in bone marrow transplantation patients. Am J Clin Nutr 72:181\u2013189","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"790_CR25","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/sj.bmt.1701321","volume":"22","author":"SA Brown","year":"1998","unstructured":"Brown SA, Goringe A, Fegan C, Davies SV, Giddings J, Whittaker JA et al (1998) Parenteral glutamine protects hepatic function during bone marrow transplantation. Bone Marrow Transplant 22(3):281\u2013284","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"790_CR26","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S1470-2045(03)01034-9","volume":"4","author":"KA Slaviero","year":"2003","unstructured":"Slaviero KA, Clarke SJ, Rivory LP (2003) Inflammatory response: an unrecognised source of variability in the pharmacokinetics and pharmacodynamics of cancer chemotherapy. Lancet Oncol 4(4):224\u2013232","journal-title":"Lancet Oncol"},{"issue":"6","key":"790_CR27","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/clpt.1994.82","volume":"55","author":"YL Chen","year":"1994","unstructured":"Chen YL, Le V, Leneveu A, Dreyfus F, Stheneur A, Florentin I et al (1994) Acute-phase response, interleukin-6, and alteration of cyclosporine pharmacokinetics. Clin Pharmacol Ther 55(6):649\u2013660","journal-title":"Clin Pharmacol Ther"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-005-0790-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-005-0790-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-005-0790-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T01:59:10Z","timestamp":1559095150000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-005-0790-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,15]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["790"],"URL":"https:\/\/doi.org\/10.1007\/s00520-005-0790-y","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3,15]]}}}